Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (2)	5/22/2001 3:41:44 PM
From: tuck	Read Replies (2) of 1005

Compare this chart siliconinvestor.com to Rick's in post #2 siliconinvestor.com Looking at the common parameters alone, price and volume, what do the technicians/chart readers in the audience think? This is a trickle stock that I know well, a company whose products address the medicinal chemistry bottlenecks downstream of all those targets and libraries we now have. Yahoo's cash figures are accurate: biz.yahoo.com Its business should show renewed life in the 3Q01, and the company still foresees profitability in 1H02. Their current burn rate, you ask? ~$2 million per quarter. BLUE HP makes its first move. Buys 2000 shares of AGNT @ $4.80. You guys want therapeutic or genomics companies in here? Show me the research! Edit: Disclosure: BLUE HP manager just purchased some AGNT in real life at exactly the above price. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next